Spiber Inc.
Daniel Meyer currently serves as President of both Spiber Holdings America Inc. and Spiber America LLC since September 2020, following a tenure as Executive Officer at Spiber Inc. since July 2015, where previous roles included Head of Global Corporate Planning and Business Development Officer. Meyer has experience as Director at Synplogen Co., Ltd. from September 2018 to March 2021, contributing to the development of a long-chain DNA synthesis business. Additionally, Meyer worked as a Freelance Translator and participated in the Japan Exchange and Teaching Program, gaining language skills and cultural insights. Daniel Meyer holds a Bachelor of Arts degree in International Business from Seattle Pacific University. Areas of expertise include biotechnology, alternative energy, and entertainment.
This person is not in any teams
This person is not in any offices
Spiber Inc.
Established in September 2007, Spiber Inc. is a Japanese biotechnology startup utilizing cutting-edge synthetic biology, polymer, and material science for the development of Brewed Protein™, a novel protein-based material that can be used to create fibers, films, resins, and more. Produced through microbial fermentation and utilizing agricultural feedstocks as their primary raw material, Brewed Protein™ materials are well-positioned to make significant contributions to animal-free and plastic-free initiatives in a range of fields, such as the apparel and automotive industries. Spiber has raised 35.4 billion yen (as of Oct 2020; more than 330 million USD) to date, and is currently engaged in the construction of its first overseas plant, scheduled to begin operating in 2021.